GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.43+0.25 (+7.86%)
Close on Nov 18, 2026Market cap $154.73MP/E –Yield –
GT Biopharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2015 it was -79485.2%, against -38506.6% the year before. The highest annual figure on record is -136.1% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | -79485.2% | −40978.6 |
| FY2014 | Dec 31, 2014 | -38506.6% | −38370.4 |
| FY2013 | Dec 31, 2013 | -136.1% | +1375.8 |
| FY2012 | Dec 31, 2012 | -1512.0% | +12718.8 |
| FY2011 | Dec 31, 2011 | -14230.8% | +12996.5 |
| FY2010 | Dec 31, 2010 | -27227.3% | – |
See a number that looks wrong?